OSU James Cancer Hospital & Solove Research Institute  
 
Human Cancer Genetics Program
HomeAbout the ProgramResearchTraining OpportunitiesShared ResourcesFaculty & Staff
 
Home > Faculty & Staff > Faculty > Guido Marcucci



Administration
Faculty
Michael A. Caligiuri
Carlo M. Croce
Albert de la Chapelle
Samir Acharya
Doreen Agnese
Dawn Allain
William E. Carson III
Ramana Davuluri
Richard Fishel
Harold A. Fisk
Louise Fong
Michael A. Freitas
Joanna Groden
Denis C. Guttridge
Heather Hampel
Kay Huebner
Tim Hui-Ming Huang
Kimberly M. Kelly
Lawrence S. Kirschner
Gustavo Leone
Chang-Gong Liu
Guido Marcucci
Rebecca S. Nagy
Tatsuya Nakamura
Michael Ostrowski
Yuri Pekarsky
Danilo Perrotti
Robert Pilarski
Christoph Plass
Matthew D. Ringel
Christoph Schmutte
Leigha Senter
Amy Sturm
Kevin Sweet
Stephan M. Tanner
Amanda E. Toland
Michael B. Weinstein
Judith Westman
For Faculty and Staff
Guido Marcucci

Guido Marcucci, MD
Assistant Professor
Department of Internal Medicine - Division of Hematology & Oncology
A437B Starling Loving Hall
320 West 10th Avenue
Columbus, OH 43210

Phone: (614) 293-5468
Fax: (614) 293-7527
guido.marcucci@osumc.edu

Research Interests
Molecular Biology and Cancer Genetics 
Experimental Therapeutics

Select Publications
Loss of C/EBP alpha and favorable prognosis of acute myeloid leukemias: a biological paradox. Perrotti D, Marcucci G, Caligiuri MA. J Clin Oncol 22(4): 582-284, 2004.

BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B study Whitman SP, Marcucci G, Caligiuri MA, de la Chapelle A, Bloomfield CD. Blood 102(5): 1613-1618, 2003. 

Characterization of leukemia-associated Rho guanine nucleotide exchange factor (LARG) expression during murine development Caligiuri MA, Marcucci G. Cell Tissue Res 314(3): 361-366, 2003.

Core binding factor (CBF) primary acute myeloid leukemia: Is the molecular monitoring by RT-PCR useful clinically Marcucci G, Bloomfield CD, Caligiuri MA. Eur J Haematol 71(3): 143-154, 2003.

Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells Parthun MR, Whitman SP, Chan KK, Rush LJ, Plass C, Grever MR, Byrd JC, Marcucci G. Leukemia 17(2): 350-358, 2003.

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase-8-mediated apoptosis and downregulation of c-FLIP protein Parthun MR, Marcucci G, Grever MR, Byrd JC. Blood 102(2): 652-658, 2003.

Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines Parthun MR, Marcucci G.

Invest Ophthalmol Vis Sci 44(6): 2390-2398, 2003.

Differential expression of histone post-translational modification in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometry Freitas MA, Parthun MR, Marcucci G, Byrd JC. J Am Soc Mass Spectrom 15(1): 77-86, 2003.

Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor in the blood Byrd JC, Marcucci G, Grever MR, Chan KK. Rapid Commun Mass Spectrom 17(8): 757-766, 2003.




Arthur G. James Cancer Hospital and
Richard J. Solove Research Institute

646 Medical Research Facility
420 West 12th Avenue
Columbus, OH 43210
Telephone: 614.292.0642
Fax: 614.688.3981
Contact Us
OSU James Cancer Hospital and Solove Research Institute